The latest company updates, technical articles, and industry content.
Nanjing Junzhuo has completed Master File registration for hydroxyapatite raw material intended for plasma-spraying applications.
View Details
Nanjing Junzhuo has completed Master File registration for injectable filling hydroxyapatite microspheres with China's medical-device review center.
View Details
CaHA and HAP differ in composition, structure, handling characteristics, and suitability for different applications.
View Details
New domestic and international research on CaHA microspheres is clarifying how particle design, formulation strategy, and clinical positioning continue to evolve.
View Details
Questions around the complete degradation of hydroxyapatite remain important because resorption behavior directly affects long-term material performance.
View Details
A 2024 high-end medical-aesthetics summit highlighted hydroxyapatite, compliance expectations, and the industry's shift toward higher-quality development.
View Details